Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of the topical SB011 formulation in lesional skin of patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SB011

Snippet

Sponsor: Sterna Biologicals GmbH & Co. KG | Conditions: Mild to Moderate Atopic Dermatitis | Phase 2 | Status: COMPLETED